SCHEMBL978140

SCHEMBL978140

CCCCN(CCC[Si](OC)(OC)OC)c1nc(N)nc(NCCC[Si](OC)(OC)OC)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC29A1 Q99808 3/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
LMNA P02545 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HSP90AA1 P07900 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
CASP3 P42574 1/20 0.36
HTT P42858 1/20 0.36
CDK9 P50750 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
TLR8 Q9NR97 8/20 0.36
TLR7 Q9NYK1 4/20 0.36
CRHR1 P34998 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL978050 0.95 HTR7 (0.34) SLC29A1MEN1KMT2ALMNAKDM4E
SCHEMBL2370354 0.86 SLC29A1 (0.49) SLC29A1MEN1KMT2ALMNAKDM4E
SCHEMBL975684 0.85 SLC29A1 (0.34) SLC29A1MEN1KMT2ALMNAKDM4E
SCHEMBL25434244 0.80 SLC29A1 (0.49) SLC29A1MEN1KMT2ALMNAKDM4E
SCHEMBL11293174 0.80 SLC29A1 (0.49) SLC29A1MEN1KMT2ALMNAKDM4E
SCHEMBL25215379 0.80 HTR7 (0.43) MEN1KMT2ALMNAKDM4ENPC1
SCHEMBL14715387 0.80 SLC29A1 (0.60) SLC29A1MEN1KMT2ALMNAKDM4E
SCHEMBL20740706 0.78 SLC29A1 (0.39) SLC29A1KMT2ASMN1; SMN2CRHR1
SCHEMBL23327153 0.78 SLC29A1 (0.33) SLC29A1MEN1KMT2ALMNAKDM4E
SCHEMBL976008 0.77 HTR7 (0.39) KMT2AMAPTMAPK1HTTHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2289898-B1 Melamine-functional organosilicon compound and making method SHINETSU CHEMICAL CO (JP) 2017-05-03 EP disclosed
US-8263766-B2 Melamine-functional organosilicon compound and making method SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-09-11 US disclosed
EP-2289898-A1 Melamine-Functional organosilicon compound and making method Shin-Etsu Chemical Co., Ltd. (JP) 2011-03-02 EP disclosed
US-20110003989-A1 MELAMINE-FUNCTIONAL ORGANOSILICON COMPOUND AND MAKING METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003989-A1 MELAMINE-FUNCTIONAL ORGANOSILICON COMPOUND AND MAKING METHOD MEN1, MSH6, PRMT6 SLC29A1 671/4885MEN1 1/4885KMT2A 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.